<qa>  What was the IGA score?Treatment of inflammatory lesions of moderate to severe acne vulgaris in subjects 9 to 45 years of age with oral sarecycline 1.5 mgkgday compared to placebo in the subjects with moderate to severe facial acne vulgaris based on Investigators Global Assessment IGA score and inflammatory lesion counts. Safety monitored and evaluated throughout 12-week study. 